Skip to content

Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65

Prévention du Cancer du Col de l'UTÉrus Par dépistage d'Une Infection Partageable Sexuellement

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05414929
Acronym
CUTE-IPS
Enrollment
400
Registered
2022-06-10
Start date
2022-04-04
Completion date
2022-06-30
Last updated
2022-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV Infection, Cervical Cancer Screening

Brief summary

We propose a cross-sectional study to explore the acceptability and feasibility of HPV self-sampling among Quebec women. The study will invite eligible women to self-sample for HPV at home. The HPV risk factors of patients included in the study will be taken into consideration (vaccination, smoking, number of partners, date of last screening, etc.).

Interventions

DIAGNOSTIC_TESTHPV self-sampling

HPV self-sampling (Cobas Uniswab)

Sponsors

Université de Sherbrooke
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Speak and understand French without help * Have internet access (for completing forms) * Have a mailing address

Exclusion criteria

* Known positive HPV status • Have already had a hysterectomy

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the acceptability of HPV self-sampling by patients2 months following recruitmentpercentage of patients who prefer HPV testing to traditional cytology

Secondary

MeasureTime frame
Evaluate the percentage of samples collected correctly by patients2 months following recruitment
Evaluate the return rate of mailed kits2 months following recruitment
Calculate the HPV positivity rate in a population sample2 months following recruitment

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026